Indispensable to routine and esoteric clinical diagnostics, immunoassays are featured alongside clinical chemistry in highly automated integrated chemistry stations through manually intensive, wet enzyme immunoassay (EIA) plates for specialty infectious disease and autoimmune testing. Immunoassays are also used throughout the world for serological screening of donated blood and plasma. Recent reports from Kalorama Information offer market insights into immunoassay applications for autoimmune, infectious disease, and blood bank testing worldwide.
- Display 45 Products per page
Published: October 5, 2017 | Price: $2,800.00 – $5,600.00
World Market for Infectious Disease Immunoassays This report contains important business data for the infectious disease immunoassay, market, a high-growth area of immunoassy IVD testing. The report contains: Global Lab-based Infectious Disease Immunoassay Market Sizing for the following infection types: Hepatitis HIV STD TORCH Respiratory HAIs Other Infectious Disease Kalorama Information's report, The World Market for Infectious Disease Immunoassays, provides important business planning data for companies in the immunoassay market, investing in the field, or considering expansion. The following are...Published: October 1, 2009 | Price: $995.00 – $1,990.00
Diagnostic tests are an essential tool for confirming the health status of animals. The global impact of diseases such as bovine spongiform encephalopathy, foot and mouth disease, and highly pathogenic avian influenza has revealed that diagnostic tests play a key role not only in facilitating safe trade but also in many other areas such as the early detection of new diseases and the control of exotic or enzootic animal diseases. The market emerged from nascence in the early 2000s and...Published: June 27, 2016 | Price: $3,196.00 – $6,720.00
United States Market for In Vitro Diagnostic Tests United States Market for In Vitro Diagnostic Tests takes a considered look at the U.S. in vitro diagnostics (IVD) market and examines what current market trends mean for diagnostic manufacturers and investors. This report includes important tools for business planners. Included are market size estimates and forecasts for the following U.S. IVD segments: Clinical Chemistry Market (2015/2020) Identification and Antibiotic Susceptibility Testing (ID/AST) Microbiology (Traditional) Market – Automated ID/AST, Manual/Semi‐Auto ID/AST, Blood...Published: January 8, 2018 | Price: $2,995.00 – $5,990.00
Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)Tumor Markers Immunoassay Market analyzes the current world market, including tumor markers immunoassay revenues by marker, 2015-2025 (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others, Total); regional revenues for tumor markers immunoassays, 2015-2025 (US, EU, ROW, Total); attributes of selected tumor marker immunoassays (cancer type, tissue analyzed, how used); and selected...Published: April 10, 2018 | Price: $4,500.00 – $9,000.00
The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology) Microbiology has always been a major segment of the diagnostic market because the burden of infectious diseases is high. This important field is attracting even more attention today as the because of the large and growing problem of antibiotic resistance. The Worldwide Microbiology Market provides current market (2017) and market projections (to 2022) by segment (traditional microbiology, microbiology/infectious disease immunoassays, molecular microbiology, mass spectrometry in...Published: September 27, 2017 | Price: $3,600.00 – $7,200.00
The Market for Lab-Developed Test Services and the Market for Instruments and Reagents Sold to Labs This is a unique report with a unique segmentation to help customers find the right segment for their needs. Two separate but related markets are discussed in this report: the market for clinical laboratory services using laboratory developed tests, and the market for products (platforms and consumables) sold to clinical laboratories who uses these products to make LDTs. Both are large and rapidly...Published: September 24, 2020 | Price: $5,500.00 – $11,000.00
Laboratory developed tests (LDTs) are not a new or recent phenomenon but due to the incredible need for testing of SARS-CoV-2, there has been a flood of new tests and the regulatory guidance has changed dramatically. Historically, these tests were called “home-brew tests” or “in-house tests.” Also, historically, these tests were low-volume, simple and well characterized tests for low-risk diagnostic applications. Today, high-risk, complex tests have been developed as LDTs, and are being used to provide clinical results to physicians...Published: August 13, 2014 | Price: $1,995.00 – $3,990.00
The in vitro diagnostics (IVD) market attracts considerable interest. There are hundreds of participating companies, competing in multiple areas of testing. Each IVD segment could be said to function as an industry in and of itself. There are companies who specialize in one area and companies who participate across segments. There are myriad products, from routine blood tests to complicated molecular assays and new sequencing based technologies. It's often necessary for competitors to know about all of the segments of testing as different technologies can...Published: August 22, 2016 | Price: $3,600.00 – $7,200.00
This Kalorama Information report, The Worldwide Market for In Vitro Diagnostic Tests, represents the 10th edition of this comprehensive look at the IVD industry. At 1,600 pages report provides market size estimates and projections for the entirety of the clinical diagnostics testing market. It also profiles hundreds of competitors, notes significant acquisitions and other deals, discusses trends and breaks out regional and country markets. The report provides market size and forecasts to 2021 for defined segments of the IVD...Published: October 21, 2013 | Price: $3,995.00 – $7,990.00
Infectious diseases are among the most challenging issues facing health care delivery systems around the world today. The World Health Organisation estimates that more than 17 million people die of an infectious disease each year, with many of these acquired in hospitals. This Kalorama Information report, The World Market for Infectious Disease Diagnostic Tests, takes a comprehensive look at the markets for companies of testing products that can combat infectious disease threats. One of the Most Dynamic Areas of the...Published: November 1, 2015 | Price: $3,500.00 – $7,000.00
The World Market for Infectious Disease Diagnostic Tests World Market for Infectious Disease Tests provides detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing and blood screening and subsegments within. POC and home testing markets for infectious disease are also provided. Sales and forecasts of infectious disease reagents are made through to 2019. Emerging products and markets are described; key players and strategies discussed and competitive trends...Published: November 6, 2013 | Price: $3,995.00 – $7,990.00
The World Market for Immunoassays Visit our Immunoassays curated page for complete industry coverage. The immunoassay market is large and long-established, but at the same time highly competitive. Kalorama Information’s newly published report, The World Market for Immunoassays, describes the opportunities that exist for large IVD companies adopting new strategies and for new entrants to take market share. Immunoassays have been used in clinical laboratory medicine since the 1960s, and are indispensable tools in clinical diagnostics. A wide range of...Published: October 17, 2019 | Price: $5,000.00 – $10,000.00
Given its effectiveness in detecting and monitoring treatment of diabetes, HbA1c has become a high-growth and highly competitive market in IVD testing. Globally, a growing amount of dollars is being spent annually on HbA1c testing, for both professional and self-testing. Over a dozen companies produce analyzers, reagents, workstations, and point-of-care (POC) devices that run HbA1c tests. A major contributing factor to growth is the growing availability of HbA1c testing both at the professional level and at the self-testing level. Kalorama’s...Published: March 23, 2021 | Price: $5,000.00 – $10,000.00
Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. This report focuses on diagnostics. The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2015 to 2024,...Published: September 11, 2015 | Price: $1,995.00 – $3,995.00
The World Market for Cancer Diagnostics, 2014-2019, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays) Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence. The World Market for Cancer Diagnostics, 6th Edition., as well as relevant industry merger data provided by Kalorama Information,...Published: July 23, 2019 | Price: $5,000.00 – $10,000.00
Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2014 to 2024, with 2019...Published: January 31, 2015 | Price: $1,995.00 – $3,990.00
The Market for IVD in Latin America The Market for IVD in Latin America is an essential resource for IVD companies seeking market information for developing countries with growing economies. Kalorama Information, and VA Consultadora y Asociados of Argentina have published detailed nation by nation market analysis of the IVD markets in LATAM and thier segment markets. Each country in Latin America is different in terms of their healthcare system, insurance services, laws and industry participants. For this reason, this...Published: August 19, 2015 | Price: $1,995.00 – $3,990.00
The IVD Market in Vietnam presents current analysis of the Vietnamese IVD industry. Vietnam has demonstrated fast economic growth in recent years. Increases in foreign investment, wages, trade, industrialization and tourism have led to economic growth higher than that of many other economies in Asia. As a result, IVD companies searching for emerging market areas to pursue growth that is no longer possible in developed nations have targeted Vietnam. The report takes an in-depth look at the market, providing data...Published: September 14, 2018 | Price: $2,500.00 – $5,000.00
The IVD Market in VietnamThe IVD Market in Vietnam provides an overview of the in vitro diagnostics market in Vietnam and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in Vietnam, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry, blood gas analysis, urinalysis, infectious...Published: July 5, 2018 | Price: $3,995.00 – $7,990.00
The search for emerging markets is necessary part of growth strategy in IVD. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. This report provides an overview of developments in the in vitro diagnostics industry in the Middle East. The countries covered are: Egypt Iran Iraq Israel Jordan Saudi Arabia Turkey United Arab Emirates (UAE) Other Mideast The Middle East market for in vitro diagnostics is provided in U.S....Published: September 13, 2018 | Price: $2,500.00 – $5,000.00
The IVD Market in South Korea The IVD Market in South Korea provides an overview of the in vitro diagnostics market in South Korea and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in South Korea, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry,...Published: February 1, 2010 | Price: $2,500.00 – $5,000.00
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) Clinical laboratories are an essential part of the health industry. Kalorama Information estimates that approximately 80% of physicians' diagnoses are a result of laboratory tests.he constant pressure to reduce healthcare spending is shifting healthcare utilization in favor of the laboratory, making it an ever more valuable part of the treatment plan. As hospital stays are shortened, contact between the physician and patient is reduced, which places a larger role...Published: March 28, 2018 | Price: $1,500.00 – $3,000.00
Convenience clinics are designed to occupy small spaces and provide just basic care. Therefore, they do not use most of the sophisticated medical equipment found in hospitals or specialty centers such as advanced imaging devices. In fact, while a few larger centers have x-ray machines, most do not. However, retail clinics are becoming relatively large users of point-of-care (POC) tests, clinical chemistry and immunoassay laboratory tests and vaccines. This chapter examines the effect of retail clinics on each of these...Published: August 15, 2014 | Price: $3,995.00 – $7,990.00
Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based Chemistry, Glucose, Coagulation PT, Autoimmune, HIV, Hep, Cardiac Markers, PSA, Flu, HbA1c, Hematology, FOB and Other Tests) Physician office laboratories are a diverse but significant market for IVD products. The range of POLs is vast: Individual physicians may peform in-office pregnancy and glucose tests, run automated CBCs and chemistry panels or perform moderate complexity infectious disease tests using plate immunoassays and molecular assays. This report, Physician Office Laboratory Markets is...Published: March 1, 2011 | Price: $1,500.00 – $2,500.00
This bundle provides customers with three of the most intensely researched Kalorama Information reports covering the diagnostic industry authored by Shara Rosen, R.T., M.B.A. in 2010 and 2011 These reports will be provided in one PDF, each with its own table of contents. The bundle allows customers to save almost $4,500 off the cost of the individual reports. THE WORLDWIDE MARKET FOR IN VITRO DIAGNOSTIC TESTS, 7th Edition This 900 page report contains coverage of all segments of In Vitro...Published: October 11, 2019 | Price: $5,000.00 – $10,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2019-2024 saves time with calculations and estimates of the both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD...Published: January 1, 2014 | Price: $1,995.00 – $3,995.00
IVD in Singapore and Malaysia Regional opportunities are the focus of IVD manufacturers that seek marginal growth. Southeast Asia represents a unique market for healthcare providers and their various business suppliers, including the in vitro diagnostics (IVD) industry. Kalorama details in this report two countries expected to provide business for IVD manufacturers: Singapore and Malaysia. IVD in Singapore and Malaysia contains the following information: Healthcare Statistics for Singapore and Malaysia Significant Hospitals in both countries The Clinical Lab Market in...Published: January 6, 2016 | Price: $3,360.00 – $6,720.00
IVD in India IVD in India provides analysis of the Indian IVD industry and presents projections to 2025, featuring estimates of the total opportunity and its component sectors, including: total IVD revenues in India, 2015-2025, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2015, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2020, and IVD revenues in India by market sector (immunoassays, clinical chemistry,...Published: September 9, 2018 | Price: $5,000.00 – $10,000.00
Kalorama Information 2018 Regional IVD Market Bundle (IVD in China, The IVD Market in South Korea, The IVD Market in Vietnam) This Kalorama Information (KI) Market Research Bundle is a combination of 3 complete KI in vitro diagnostics (IVD) reports, including IVD in China, The IVD Market in South Korea and The IVD Market in Vietnam. The reports provide an overview of the IVD markets in China, South Korea and Vietnam. The revenue data provided give an overview of developments...Published: June 11, 2015 | Price: $1,995.00 – $3,995.00
IVD in China Market Outlook 2014-2024 With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro diagnostics (IVD) market, China trails only the populous, developed markets of the United States, western European countries,...Published: August 5, 2013 | Price: $2,500.00 – $5,000.00
This report, IVD in China represents Kalorama's complete analysis on the Chinese IVD market. The report provides an introduction to the healthcare system in China, the results of recent reform efforts, and issues and trends. Regional breakouts of the Chinese system are provided. The report describes the role that out-of-pocket expenditures and private concerns play in the delivery of healthcare in the nation. The modern Chinese healthcare market was borne of and continues to be guided by the progressive intentions...Published: April 12, 2018 | Price: $3,995.00 – $7,990.00
IVD in China As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. This report provides the following market data: Market by Province (Guangdong, Shangdong, Henan, Sichuan, Jiangsu, Hebei, Hunan, Anhui, Zhejiang,...Published: April 30, 2019 | Price: $5,500.00 – $11,000.00
Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Most of the leading industry competitors as well as a sizable number of specialized IVD concerns are active in this product segment. The detection and characterization of infectious diseases hold promising worldwide growth potential as discussed in Kalorama’s Infectious Disease Diagnostics: World Market Analysis: HIV/AIDS, Hepatitis, Tuberculosis, STDs, HAIs, ID/AST, Influenza, TORCH, Other. The World Infectious Disease Testing Market...Published: February 26, 2018 | Price: $5,500.00 – $11,000.00
Infectious Disease Testing: World Market Analysis (HIV, Hepatitis, Blood Screening With over 400 tables to illustrate the analysis and provide solid business planning metrics, The World Market for Infectious Disease Diagnostic Diagnostics Testing, covers 30 areas of infectious diseases in 25 countries and regions. Diseases and technology categories segmented and forecasted in this report include: Blood Screening Immunoassay Blood Screening NAT Influenza Tests Strep A Test RSV Testing Malaria Tests Dengue Testing HIV Tests – Laboratories HIV Tests – POC...Published: April 7, 2022 | Price: $6,000.00 – $12,000.00
The Most Comprehensive and Reliable Market Sizing and Forecasts in Infectious Disease IVD [caption id="attachment_18836" align="aligncenter" width="300"] Attend a WEBINAR on this topic.[/caption] Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the...Published: October 12, 2017 | Price: $4,796.00 – $9,600.00
Published: May 1, 2009 | Price: $250.00 – $3,395.00
It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro...Published: September 6, 2017 | Price: $3,600.00 – $7,200.00
Immunoassay Markets (Infectious Disease, Tumor Markers, Thyroid, Allergy, Drugs of Abuse, Therapeutic Drug Monitoring, Others) This report, from Kalorama Information, the premier market research publisher in in vitro diagnostics, features the following market data: Global Immunoassay Market, 2017-2021 Historical Market 2014-2016 ELISA Markets Radioimmunoassay Markets Lab-baded Immuonassay Markets POC Immumonassays Infectious Disease Immunoassays - (Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease) Tumor Marker Immunoassays Thyroid Metabolic and Other Hormone Immunoassays Therapeutic Drug Monitoring Immunoassays Drugs of Abuse Immunoassays...Published: December 6, 2017 | Price: $1,200.00 – $2,400.00
Human Microbiome Applications in IVD and Other Healthcare Human Microbiome Applications in IVD and Other Healthcare examines the growing interest in the human microbiome in in vitro diagnostics and other healthcare applications. This report notes IVD company interest in the microbiome, including selected microbiome-based tests, including selected molecular tests; microbiome-based diagnostic biomarkers; and precision or personalized medicine approaches to the microbiome. Human Microbiome Applications in IVD and Other Healthcare notes pharmaceutical company interest in the microbiome as well. Discussed are...Published: October 25, 2017 | Price: $3,600.00 – $7,200.00
HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) Kalorama Information’s HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) provides market size and growth of the global HIV testing market, including: Global HIV Testing Market, 2015-2022 (in millions at manufacturer level) Global HIV Testing Market Share Percent by Test Category, 2017 (%; Lab-based, Molecular, POC) Global HIV Testing Market Share Percent by Test Category, 2022 (%; Lab-based, Molecular, POC) The three categories of the global HIV testing market – lab-based immunoassay HIV testing,...Published: May 19, 2020 | Price: $5,000.00 – $10,000.00
Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, hemoglobin (automated, manual), sedimentation rate, reticulocyte count, white blood cell (WBC) count, platelet count and analysis, and red blood...Published: September 7, 2017 | Price: $2,400.00 – $4,800.00
This report takes a look at both prevention procedures such as sterilization and surface area disinfection and testing such as molecular tests and immunoassays. Infection control in healthcare facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of healthcare is known as a nosocomial, or hospital acquired, infection. What...Published: May 1, 2009 | Price: $250.00 – $1,600.00
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...Published: July 1, 2007 | Price: $995.00 – $3,990.00
In light of laboratory pressures to do more with less, laboratory managers transfer cost control onto vendors by means of a constant push for price reductions. In this commercial climate, efficient management of customer and technical service extras is critical. Expertise in managing service offerings will help companies offer service programs that are just enough to differentiate them from the competition. Service programs that offer too much may result in revenue loss. Programs that are perceived to be inadequate place...Published: October 31, 2019 | Price: $3,000.00 – $6,000.00
This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing New POC Innovations Cancer Testing and Personalized Medicine Hematology Glucose Monitoring Advancements HbA1c Testing New Developments in Infectious Diseases Cytology - Increasing Molecular Dx Options...